Tachyarrhythmia and Interstitial lung disease

Summary:

Interstitial lung disease is found among people with Tachyarrhythmia, especially for people who are female, 60+ old.

The study analyzes which people have Interstitial lung disease with Tachyarrhythmia. It is created by eHealthMe based on reports of 16 people who have Tachyarrhythmia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Tachyarrhythmia?

Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased) is found to be associated with 420 drugs and 901 conditions by eHealthMe. Check the latest studies of Tachyarrhythmia.

What is Interstitial lung disease?

Interstitial lung disease is found to be associated with 1,500 drugs and 1,841 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

16 people who have Tachyarrhythmia and Interstitial Lung Disease are studied.

Would you have Interstitial lung disease when you have Tachyarrhythmia?

Gender of people who have Tachyarrhythmia and experienced Interstitial Lung Disease *:

female: 75 %
male: 25 %

Age of people who have Tachyarrhythmia and experienced Interstitial Lung Disease *:

Common co-existing conditions for these people *:

Depression: 6 people, 37.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 37.50%
Ovarian Cancer (cancer of ovary): 5 people, 31.25%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 4 people, 25.00%
Hypokalemia (low potassium): 4 people, 25.00%
Arrhythmias (irregular heartbeat): 4 people, 25.00%
Breast Cancer: 4 people, 25.00%
Cardiac Failure Acute: 4 people, 25.00%
Chest Injury: 4 people, 25.00%
Dyspnea (difficult or laboured breathing): 4 people, 25.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Blood Creatinine Increased: 6 people, 37.50%
Weakness: 4 people, 25.00%
High Blood Pressure: 4 people, 25.00%
Anaemia (lack of blood): 4 people, 25.00%
Cardiac Valve Disease (heart valve disease): 4 people, 25.00%
Chapped Lips (cracking, fissuring, and peeling of the skin f lip): 4 people, 25.00%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 4 people, 25.00%
Dry Skin: 4 people, 25.00%
Thrombocytopenia (decrease of platelets in blood): 4 people, 25.00%
Hair Loss: 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Interstitial lung disease?

- Check whether Interstitial lung disease is associated with a drug or a condition

Related publications that referenced our studies

Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Interstitial lung disease and Tachyarrhythmia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.